Suppr超能文献

α-突触核蛋白与小胶质细胞在 α-突触核蛋白病中的相互作用。

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies.

机构信息

Department of Pathology and Laboratory Medicine, University of California, Irvine, CA 92697, USA.

UCI Institute for Neurotherapeutics, University of California, Irvine, CA 92697, USA.

出版信息

Int J Mol Sci. 2023 Jan 27;24(3):2477. doi: 10.3390/ijms24032477.

Abstract

Synucleinopathies are a set of devastating neurodegenerative diseases that share a pathologic accumulation of the protein α-synuclein (α-syn). This accumulation causes neuronal death resulting in irreversible dementia, deteriorating motor symptoms, and devastating cognitive decline. While the etiology of these conditions remains largely unknown, microglia, the resident immune cells of the central nervous system (CNS), have been consistently implicated in the pathogenesis of synucleinopathies. Microglia are generally believed to be neuroprotective in the early stages of α-syn accumulation and contribute to further neurodegeneration in chronic disease states. While the molecular mechanisms by which microglia achieve this role are still being investigated, here we highlight the major findings to date. In this review, we describe how structural varieties of inherently disordered α-syn result in varied microglial receptor-mediated interactions. We also summarize which microglial receptors enable cellular recognition and uptake of α-syn. Lastly, we review the downstream effects of α-syn processing within microglia, including spread to other brain regions resulting in neuroinflammation and neurodegeneration in chronic disease states. Understanding the mechanism of microglial interactions with α-syn is vital to conceptualizing molecular targets for novel therapeutic interventions. In addition, given the significant diversity in the pathophysiology of synucleinopathies, such molecular interactions are vital in gauging all potential pathways of neurodegeneration in the disease state.

摘要

突触核蛋白病是一组破坏性的神经退行性疾病,它们具有共同的病理性α-突触核蛋白(α-syn)积累。这种积累导致神经元死亡,从而导致不可逆转的痴呆、运动症状恶化和认知能力灾难性下降。虽然这些疾病的病因在很大程度上仍然未知,但中枢神经系统(CNS)的常驻免疫细胞小胶质细胞一直被认为与突触核蛋白病的发病机制有关。小胶质细胞通常被认为在α-syn 积累的早期具有神经保护作用,并在慢性疾病状态下导致进一步的神经退行性变。虽然小胶质细胞实现这一作用的分子机制仍在研究中,但我们在此强调迄今为止的主要发现。在这篇综述中,我们描述了固有无序的α-syn 的结构多样性如何导致不同的小胶质细胞受体介导的相互作用。我们还总结了哪些小胶质细胞受体能够使细胞识别和摄取α-syn。最后,我们综述了α-syn 在小胶质细胞内的加工的下游效应,包括向其他脑区传播,导致慢性疾病状态下的神经炎症和神经退行性变。了解小胶质细胞与α-syn 的相互作用机制对于构思新型治疗干预的分子靶点至关重要。此外,鉴于突触核蛋白病的病理生理学存在显著差异,这种分子相互作用对于评估疾病状态下所有潜在的神经退行性变途径至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cb/9916729/29d64541ea06/ijms-24-02477-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验